[{"address1": "4000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 822 5600", "website": "https://www.kezarlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher J. Kirk Ph.D.", "age": 52, "title": "Co-Founder, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 927300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Franklin Fowler", "age": 52, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 57037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc L. Belsky CPA", "age": 69, "title": "CFO & Secretary", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 653208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Schiller", "age": 44, "title": "Chief Legal Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 637985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Taunton Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pattie  Chiang", "age": 62, "title": "Principal Accounting Officer, Senior VP & Corporate Controller", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gitanjali  Jain", "title": "Senior Vice President of Investor Relations & External Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joe  Tedrick", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neel K. Anand Ph.D.", "title": "Senior Vice President of Research & Drug Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zung  To", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.06, "open": 4.0694, "dayLow": 3.9949, "dayHigh": 4.1, "regularMarketPreviousClose": 4.06, "regularMarketOpen": 4.0694, "regularMarketDayLow": 3.9949, "regularMarketDayHigh": 4.1, "payoutRatio": 0.0, "forwardPE": -0.38872972, "volume": 10005, "regularMarketVolume": 10005, "averageVolume": 32601, "averageVolume10days": 70570, "averageDailyVolume10Day": 70570, "bid": 2.96, "ask": 5.15, "bidSize": 2, "askSize": 2, "marketCap": 29734608, "fiftyTwoWeekLow": 3.62, "fiftyTwoWeekHigh": 9.2, "fiftyDayAverage": 4.7806, "twoHundredDayAverage": 6.19715, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -70516392, "profitMargins": 0.0, "floatShares": 4902630, "sharesOutstanding": 7305800, "sharesShort": 68974, "sharesShortPriorMonth": 60263, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0094, "heldPercentInsiders": 0.1157, "heldPercentInstitutions": 0.5945, "shortRatio": 3.16, "shortPercentOfFloat": 0.0097, "impliedSharesOutstanding": 7305800, "bookValue": 14.108, "priceToBook": 0.2884888, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -78634000, "trailingEps": -10.78, "forwardEps": -10.47, "lastSplitFactor": "1:10", "lastSplitDate": 1730246400, "enterpriseToEbitda": 0.86, "52WeekChange": -0.4727273, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 4.07, "targetHighPrice": 18.0, "targetLowPrice": 7.0, "targetMeanPrice": 12.5, "targetMedianPrice": 12.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 114361000, "totalCashPerShare": 15.653, "ebitda": -82022000, "totalDebt": 14110000, "quickRatio": 6.742, "currentRatio": 7.093, "debtToEquity": 13.69, "returnOnAssets": -0.32004002, "returnOnEquity": -0.57779, "grossProfits": -65742000, "freeCashflow": -42295624, "operatingCashflow": -68540000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KZR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 0.0, "longName": "Kezar Life Sciences, Inc.", "shortName": "Kezar Life Sciences, Inc.", "postMarketPrice": 4.07, "postMarketChange": 0.0, "regularMarketChange": 0.010000229, "regularMarketDayRange": "3.9949 - 4.1", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 32601, "fiftyTwoWeekLowChange": 0.4500003, "fiftyTwoWeekLowChangePercent": 0.12430947, "fiftyTwoWeekRange": "3.62 - 9.2", "fiftyTwoWeekHighChange": -5.1299996, "fiftyTwoWeekHighChangePercent": -0.55760866, "fiftyTwoWeekChangePercent": -47.272728, "earningsTimestamp": 1747166460, "earningsTimestampStart": 1754909940, "earningsTimestampEnd": 1755259200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.78, "epsForward": -10.47, "epsCurrentYear": -7.06, "priceEpsCurrentYear": -0.5764873, "fiftyDayAverageChange": -0.7105999, "fiftyDayAverageChangePercent": -0.1486424, "twoHundredDayAverageChange": -2.12715, "twoHundredDayAverageChangePercent": -0.3432465, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 0.24631105, "regularMarketPrice": 4.07, "corporateActions": [], "postMarketTime": 1747425609, "regularMarketTime": 1747425602, "exchange": "NCM", "messageBoardId": "finmb_304157325", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Kezar Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]